NOV analyst estimates
NOV (NOV) analyst ratings, the average price target and its range, and every firm's latest call.
NOV analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Jul 15, 2026 | Morgan Stanley | NOV Inc. price target raised to $21 from $20 at Morgan Stanley | $21.00 |
| Jul 8, 2026 | Susquehanna | NOV Inc. price target lowered to $22 from $24 at Susquehanna | $22.00 |
| Jun 4, 2026 | Capital One Financial | NOV Inc. upgraded to Overweight from Equalweight at Capital One | $26.00 |
| Jun 3, 2026 | Goldman Sachs | NOV Inc. price target lowered to $19 from $20 at Goldman Sachs | $19.00 |
| May 7, 2026 | Barclays | NOV Inc. downgraded to Underweight from Equal Weight at Barclays | $21.00 |
| Apr 29, 2026 | Susquehanna | NOV Inc. price target raised to $24 from $22 at Susquehanna | $24.00 |
| Apr 15, 2026 | Morgan Stanley | NOV Inc. price target raised to $20 from $18 at Morgan Stanley | $20.00 |
| Feb 9, 2026 | Piper Sandler | NOV Inc. price target raised to $18 from $17 at Piper Sandler | $18.00 |
| Feb 6, 2026 | Susquehanna | NOV Inc. price target raised to $21 from $20 at Susquehanna | $21.00 |
| Feb 6, 2026 | Stifel Nicolaus | NOV Inc. price target raised to $21 from $19 at Stifel | $21.00 |
| Feb 6, 2026 | Evercore ISI | NOV Inc. price target raised to $19 from $15 at Evercore ISI | $19.00 |
| Jan 15, 2026 | RBC Capital | NOV Inc. price target raised to $21 from $19 at RBC Capital | $21.00 |
| Jan 14, 2026 | Goldman Sachs | NOV Inc. price target raised to $17 from $14 at Goldman Sachs | $17.00 |
| Jan 7, 2026 | Susquehanna | NOV Inc. price target raised to $20 from $17 at Susquehanna | $20.00 |
| Dec 18, 2025 | Piper Sandler | NOV Inc. price target raised to $17 from $14 at Piper Sandler | $17.00 |
- 11 firms rate NOV: 3 buy, 6 hold, 2 sell.
- The average price target is $21.80 from 5 analysts, from $19.00 to $26.00.
Updated 2026-11-02 23:11 UTC